GlassScriptPhysician profile
John Thomas Campbell, II
NPI 1053373415
$6,672.31
in general payments reported to CMS, 2019-2025
51 companies · $1,066 in 2025
The $1,066 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $548 · 2020: $695 · 2021: $1,094 · 2022: $977 · 2023: $1,257 · 2024: $1,035 · 2025: $1,066.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,357.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $993.99 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Novo Nordisk INC | $881.12 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $869.03 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $399.93 | 2020-2025 | Zepbound, Mounjaro, Jardiance |
| Pfizer INC. | $330.38 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $282.95 | 2019-2025 | Gardasil 9, Vaxneuvance, Capvaxive |
| Glaxosmithkline, LLC. | $271.09 | 2019-2025 | Shingrix, Arexvy, Bexsero |
| Amgen INC. | $242.21 | 2019-2025 | Evenity, Repatha, Otezla |
| Bausch Health US, LLC | $179.75 | 2020-2023 | Aplenzin |
| Biohaven Pharmaceutical Holding Company LTD. | $165.04 | 2022 | |
| Astellas Pharma US INC | $153.46 | 2020-2025 | Veozah |
| Esperion Therapeutics, INC. | $150.44 | 2020-2025 | Nexletol |
| Allergan, INC. | $134.76 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $120.68 | 2019-2022 | |
| Idorsia Pharmaceuticals US INC | $90.95 | 2023-2024 | Quviviq |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $87.05 | 2022-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Seqirus USA INC | $84.73 | 2024-2025 | Flucelvax, Fluad |
| Genentech USA, INC. | $79.57 | 2019-2021 | |
| Philips North America LLC | $76.57 | 2022-2024 | (Ck7) Extended Holter |
| Exeltis, USA INC. | $74.45 | 2023-2025 | Slynd |
| Cranial Technologies, INC | $70.63 | 2020-2025 | Doc Band |
| Eisai INC. | $66.48 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $65.61 | 2021 | |
| Boston Scientific Corporation | $61.45 | 2023-2025 | Axonics, Wavewriter Alpha Prime 16 |
| Amarin Pharma, INC. | $57.04 | 2019-2021 | |
| Sanofi Pasteur INC. | $54.63 | 2022-2023 | |
| Aimmune Therapeutics, INC. | $51.28 | 2025 | Zenpep |
| Shire North American Group INC | $48.00 | 2019 | |
| Exact Sciences Corporation | $44.68 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Nevro Corp. | $38.34 | 2022-2023 | Senza |
| Bayer Healthcare Pharmaceuticals INC. | $34.18 | 2022-2023 | |
| Ironwood Pharmaceuticals, INC | $32.81 | 2019 | |
| Sanofi-Aventis U.S. LLC | $30.20 | 2021 | |
| Neos Therapeutics, LP | $28.59 | 2019 | |
| Arbor Pharmaceuticals, INC. | $27.13 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.44 | 2020 | |
| Ibsa Pharma INC. | $24.08 | 2025 | Tirosint, Flector, Licart |
| Hologic Sales and Service, LLC | $23.70 | 2025 | Aptima, Thinprep 2000 Processor |
| Inspire Medical Systems, INC. | $22.39 | 2023 | Inspire |
| Biogen, INC. | $21.52 | 2021 | |
| Daiichi Sankyo INC. | $18.97 | 2019 | |
| Organon LLC | $18.95 | 2025 | Nexplanon |
| Gilead Sciences, INC. | $17.83 | 2021 | |
| Ethicon US, LLC | $17.20 | 2019 | |
| Tactile Systems Technology INC | $16.35 | 2020 | |
| Inogen, INC. | $15.62 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Amneal Pharmaceuticals LLC | $15.13 | 2023 | Unithroid |
| Janssen Pharmaceuticals, INC | $14.58 | 2021 | |
| Xeris Pharmaceuticals, INC. | $13.96 | 2023 | Keveyis |
| Medtronic, INC. | $13.87 | 2025 | Inceptiv |
| Ironshore Pharmaceuticals INC. | $13.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.